Global Acne Drugs Market Report is available at MarketInsightsReports gives an overview of the Acne Drugs industry which covers market scope, revenue, opportunities, growth rate, sales volumes and figures. The report additionally explores the worldwide players of the market and is segmented by region, type and application with forecast to 2022.
Early Buyers will Get Upto 30% Off On This Report
Get an Insightful Report Sample Here @
Top Key Players Profiled in This Report:
ALLERGAN, Galderma S.A., Valeant Pharmaceutical International Inc., Teva Pharmaceutical Industries Ltd. and Johnson & Johnson Services, Inc.
The global acne drugs market was valued at about $15.45 billion in 2018 and is expected to grow to $20.48 billion at a CAGR of 7.3% through 2022.
The acne drugs market consists of sales of prescription acne drugs (Salicylic acid, Retin-A Micro, Onexton, and Solodyn) and related OTC non-prescription products (cleansers, lotions, gels, toners, masks and pads containing acne-fighting ingredients) which are used to treat skin diseases such as acne vulgaris and acne rosacea. Based on the type of acne, this market is segmented into inflammatory acne and Non-Inflammatory acne. Market in this report does not include the sales of drugs used for Dermatitis and Psoriasis.
An increase in the disposable income of people is one of the major drivers in the acne market. An increase in the disposable income is usually due to an improved economy leading to increased wages and salaries boosting healthcare expenditure. In 2018, Disposable Income in India increased 13.67% when compared to 2017 i.e. from 169 million INR to 192 million INR. Rise in disposable income increased expenditure on facial care products is expected to continue, thereby driving the market in the forecast period. Acne is a major problem worldwide, close to 90% of people suffer from some sort of acne. In America alone, close to 12 million people suffer from a severe acne problem, that can lead to scarring of the skin if left untreated, as a result many people purchase Acne care drugs and products.
Get complete report@
Scope of the Report:
Markets Covered: 1) By Type: Inflammatory Acne, Non-Inflammatory Acne 2) By End User: Hospitals & Clinics, Pharmacies & Drug Stores, Ambulatory Surgical Centres 3) By Therapeutic Class: Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Acne Drugs Indicators Comparison.
An aim of the international market is as follows:
-To present Acne Drugs Market insight over the globe.
-To evaluate and forecast the Acne Drugs Market on the basis of different segments.
-To serves market size and forecast up to 2022 for complete Acne Drugs Market related to major regions.
-To provide extensive PEST study for all Acne Drugs Market regions mentioned in the report.
-To outlines major Acne Drugs Market players regulating the industry together with their SWOT analysis and Acne Drugs Market policies.
Avail 30% Discount on this Report now@:
This research report represents a 360-degree overview of the competitive landscape of the Global Acne Drugs Market. Furthermore, it offers massive data relating to recent trends, technological advancements, tools, and methodologies. The research report analyzes the Global Acne Drugs Market in a detailed and concise manner for better insights into the businesses. Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Acne Drugs Market. The feasibility of the new report is also measured in this research report.
We also offer customization on reports based on specific client requirement:
1- Free country level analysis for any 5 countries of your choice.
2- Free Competitive analysis of any market players.
3- Free 40 analyst hours to cover any other data points
Irfan Tamboli (Sales)
Phone: + 1704 266 3234